NEW YORK(GenomeWeb) – Roche today announced it has signed a definitive agreement to acquire clinical diagnostics firm GeneWeave BioSciences for as much as $425 million.

Under the terms of the agreement, Roche will make a $190 million upfront payment to GeneWeave's shareholders and could pay an additional $235 million in product-related milestones. Once the deal is closed, Roche will integrate GeneWeave into its Molecular Diagnostics unit.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.